share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Hockfield Susan

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Hockfield Susan

辉瑞 | 4：持股变动声明-董事 Hockfield Susan
美股sec公告 ·  04/26 13:28
Moomoo AI 已提取核心信息
Susan Hockfield, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to monitor Pfizer's filings for further details on transactions by insiders.
Susan Hockfield, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to monitor Pfizer's filings for further details on transactions by insiders.
辉瑞公司 [PFE] 的举报人苏珊·霍克菲尔德参与了一项涉及该公司股票的交易。该行动于2024年4月25日举行。但是，有关交易性质的细节，例如交易的股票数量、交易价格以及由此产生的所有权，尚未披露。建议投资者监督辉瑞的申报，以了解有关内部人士交易的更多细节。
辉瑞公司 [PFE] 的举报人苏珊·霍克菲尔德参与了一项涉及该公司股票的交易。该行动于2024年4月25日举行。但是，有关交易性质的细节，例如交易的股票数量、交易价格以及由此产生的所有权，尚未披露。建议投资者监督辉瑞的申报，以了解有关内部人士交易的更多细节。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息